Rosen Law Firm announced on April 5 that purchasers of Picard Medical, Inc. common stock between September 2 and October 31, 2025, have until April 13, 2026 to seek appointment as lead plaintiff in a securities fraud lawsuit against the company.
The notice is important for investors who may be entitled to compensation if they bought shares during the specified period. The class action lawsuit alleges that Picard Medical, Inc. provided overly positive statements about its financial targets for 2027 and growth prospects for its Branded Checkout segment while concealing problems with its salesforce’s ability to achieve these goals.
According to the complaint, “defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Picard Medical, Inc.’s salesforce; notably, that it was not truly equipped to execute on Picard Medical, Inc.’s perceived growth potential and were ‘too optimistic’ as to how easily and expeditiously its staff could change customer adoption.” The lawsuit claims that when this information became public knowledge, investors suffered damages.
The Rosen Law Firm said it encourages investors “to select qualified counsel with a track record of success in leadership roles.” The firm highlights its experience representing global investors in securities class actions and shareholder derivative litigation. It reports having achieved significant settlements for clients over recent years.
No class has been certified yet in this case. Investors are not represented by counsel unless they choose one or are appointed as lead plaintiff. Participation in any future recovery does not depend on serving as lead plaintiff.
PR Newswire operates internationally across more than 170 countries with support available in over 40 languages according to the official website. Its services include press release distribution through a network involving over half a million media outlets and influencers globally according to PR Newswire. PR Newswire also offers AI-enhanced content tools and social sharing features as outlined on its official website.
